Phase 1 study of the novel immunotoxin MT-5111 in patients with HER-2+tumors.

Wainberg, ZA; Mita, MM; Barve, MA; Hamilton, EP; Brenner, AJ; Valdes, F; Ahn, D; Hubbard, J; Starr, J; Burnett, C; Pelham, J; Williams, ET; Anand, BS; Strack, T; Sandri, AM; Van Tine, BA

CANCER RESEARCH, 2021; 81 (13):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索